Informal Networking With The Professor

4 informal sessions of questions and answers with well-known professors will be held daily during the lunch breaks.


29th March 2017 -13:00 -14:00

Luc Buee, France: TAU-BASED THERAPEUTIC INTERVENTIONS/STRATEGIES

Don Cleveland, USA: GENE SILENCING: THERAPY IN THE NERVOUS SYSTEM

Marc Diamond, USA:  PRION MECHANISMS IN NEURODEGENERATION: NEW WAYS TO UNDERSTAND HOW TO DIAGNOSE AND TREAT DISEASE

Christian Haass, Germany: WHAT IS THE BEST TREATMENT STRATEGY AGAINST ALZHEIMER'S DISEASE?

Virginia M.Y. Lee, USA: PROFESSIONAL DEVELOPMENT AND CAREER CHOICES FOR PHDS AND MD/PHD

John Q. Trojanowski, USA: MISFOLDED TAU AND ALPHA-SYNUCLEIN: TRANSMISSIBLE PATHOGENS AND TARGETS FOR THERAPY

Agenta Nordberg, Sweden: MOLECULAR IMAGING IN NEURODEGENERATIVE DISORDERS

Thomas Südhof, USA: TOO MANY MEDICAL TRIALS ARE MOONSHOTS IN THE DARK


30TH MARCH, 2017 - 13:30 -14:45

Walter Koroshetz, USA: NIH RESEARCH IN PARKINSON'S & ALZHEIMER RELATED DEMENTIAS AS WELL AS THE NIH BRAIN INITIATIVE

Frank LaFerla, USA :BECOMING AN INDEPENDENT SCIENTIST AND SUCCEEDING IN ACADEMIA

Eckhard Mandelkow, Germany: TAU: STRUCTURE, BIOLOGY, PATHOLOGY

Eliezer Masliah, USA: STATUS OF FUNDING FOR ALZHEIMER'S DISEASE AND RELATED DEMENTIAS RESEARCH IN THE USA

Li-Huei Tsai, USA: USING PATTERNED NEURAL ACTIVITY TO MODULATE ALZHEIMER'S DISEASE PATHOLOGY


31 MARCH, 2017 - 13:25 - 14:45

Bart De Strooper, Belgium: FREE TOPICS DISCUSSION

Edward Koo, USA: WHAT'S CHANGED AFTER WORKING IN AD RESEARCH FOR 30 YEARS?

David Holtzman, USA: CAREER DEVELOPMENT

Jie Shen, USA: SCIENTIFIC RIGOR AND CAREER DEVELOPMENT

Peter St. George-Hyslop, Canada: CELL BIOLOGY OF NEW GENES FOR AD, FTD AND ALS

Cynthia Lemere, USA : ANIMAL MODELS -WHAT ARE THEY GOOD FOR?

Rudolph Tanzi, USA: KEEPING YOUR RESEARCH ORIGINAL


1st APRIL, 2017 -13:25 -14:45

Todd Golde, USA: ADVANCING YOUR CAREER: IT'S NOT JUST ABOUT SCIENCE 

John Hardy, United Kingdom: ONLY DO RESEARCH YOU ENJOY

Frédéric Checler, France: GAMMA-SECRETASE-LINKED CLINICAL TRIALS FAILURES: AN AMYLOID CASCADE HYPOTHESIS REBUTTAL OR JUST EXPERIMENTAL PITFALLS UNMASKED?

Reinhold Schmidt, Austria: MR IMAGING IN THE STUDY OF BRAIN AGING AND DEMENTIA

Dennis Selkoe, USA: ALPHA-SYNUCLEIN MULTIMERIZATION; AMYLOID ß-PROTEIN AS A THERAPEUTIC TARGET

Places are limited to 9 delegates per table and participation is by pre-registration only
If you have already registered, you may add this function to your current registration, by clicking here


Please note: in order to register please use the e-mail address and family name that was used in the registration process. The system will take you into your registration and once there, please select the required day and professor.
Please note that the sessions are limited to one session per conference delegate.
Registration is on a first come-first serve basis.




AD/PD™ Facebook
AD/PD™ Twitter
AD/PD™ Network

Keep Me Updated